Investors
DiagnoCure’s mission is to be the leading developer and provider of high-value diagnostics for the detection and management of cancer.
Latest News
Q2-2010 Results
Briefcase to Download
STOCK INFORMATION
| Symbol | TSX: CUR |
|---|---|
| Last trade | 1.13 |
| Open | 1.10 |
| Net change | +0.03 |
| High | 1.13 |
| Low | 1.10 |
| 52 week range | 0.75 - 1.48 |
| Volume | 10,000 |
| As of | 2010-07-29 09:30 EST |
| $CAN. Quotes are delayed. For information purposes only. |
|